Cannabis Law Report

JANUARY 4, 2022

Assay and Recently Developed, Unsupervised, At-Home Sample Collection Kit to Expand Addressable Market and Scope of COVID-19 Testing Services – STONY BROOK, N.Y.–(BUSINESS Assay”) as a Laboratory Developed Test (LDT), pending a final review of the assay’s validation data by NYSDOH. Assay (the “Linea 2.0 Assay (the “Linea 2.0

Conditions 52

Conditions Research and Development Therapy Supply Chain 52

Puff Puff Post

JANUARY 24, 2019

“There were times when I was told you couldn’t even use ‘cannabis’ and ‘research’ in the same sentence,” he recalled. which is conducting millions of dollars worth of research on the use of cannabis to treat conditions including anxiety, insomnia and pain. The federal government is investing in marijuana research too.

Research and Development 111

Research and Development Legalization Marijuana Recreational 111

The Cannigma

MARCH 14, 2023

In fact, its history as a dangerous, illicit narcotic is dwarfed by its history as a medicine. Cancer, HIV, epilepsy and other serious conditions were the first accepted uses of cannabis in the United States. Many of the early medical cannabis states had strict lists of conditions for which cannabis could be legally used.

Policy 96

Policy Research and Development Conditions Consumption 96

MMJ Recs

FEBRUARY 21, 2024

This article delves into the impact of medical marijuana on various aspects of women’s well-being, addressing key areas such as reproductive health, menstrual health, mental health, hormonal balance, pain management, wellness, and specific health conditions.

Chronic Pain 105

Chronic Pain Marijuana Research and Development Cannabinoids 105

MMJ Recs

MARCH 28, 2024

From researching qualified doctors to scheduling appointments and discussing treatment options, we provide practical insights and tips to help patients confidently navigate this journey. Patients should research and familiarize themselves with these professionals to ensure they receive appropriate guidance and care.

Patients 52

Patients Treatment Research and Development Therapy 52

Veriheal

JULY 7, 2023

Scientists stumbled upon a solution to California’s HLVd problem, Australia made psychedelic history, and a North Carolina senator is fighting for medical cannabis. Plants hit with HLVd show issues like yellow leaves, abnormal branching, stunted development, and nearly 50% loss in cannabinoid production. Do you think Sen.

Legalization 96

Legalization Clinical Trials Research and Development History 96

MMJ Recs

MARCH 14, 2024

Qualifying Conditions for Medical Marijuana in West Virginia West Virginia’s medical marijuana program encompasses an extensive list of qualifying conditions, providing access to patients with various chronic or debilitating diseases.

Dispensary 52

Dispensary Programs Legalization Marijuana 52

Cannabis Law Report

SEPTEMBER 8, 2021

Key Transaction Details: The Valens Company, a leading Canadian manufacturer of cannabis products, has entered into a long-term partnership with Epsilon, for exclusive access to the Epsilon’s GMP Manufacturing Facility in Southport , Queensland Australia (the “ Southport Facility ‘).

Access 97

Access Research and Development Medicine THC 97

MMJ Recs

OCTOBER 26, 2023

Understanding MMJ regulations on a state-by-state basis is essential for both patients seeking access to MMJ and the businesses and professionals operating within this industry. Alaska: Alaska has a robust MMJ program, allowing for the use of medical marijuana for qualifying conditions. The state has licensed dispensaries.

Law 98

Law Marijuana Programs Dispensary 98

MMJ Recs

DECEMBER 17, 2023

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. Physician’s Prescription: Patients must obtain a prescription from a qualified physician registered with the TCUP.

Law 52

Law Dispensary Clinical Trials Programs 52

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Veriheal

SEPTEMBER 27, 2021

The United Kingdom’s Multiple Sclerosis (MS) Society has taken a stand against restricted access to medical cannabis in the country. Medical cannabis has been legal in the nation for almost three years—so why are MS patients struggling to access the treatment? Yet many people with MS are still unable to access it.”

Treatment 98

Treatment Patients Access Research and Development 98

Cannabis Law Report

AUGUST 10, 2021

The UK is a significant country for us for many reasons, and we are proud to be able to offer a medicine, that has been developed and is manufactured here, to even more patients across the UK. GW’s development programme represents the only well-controlled clinical evaluation of a cannabinoid medication for patients with refractory epilepsy.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

APRIL 20, 2019

Why did this process of giving patients access to what they already have take 6 years ! Brian Kemp on Wednesday signed a bill that would fix that problem, calling the new law a carefully crafted, balanced measure that would expand access for patients in need without opening the door to recreational drug use.

Access 45

Access Oil Patients Law 45

PrestoDoctor

OCTOBER 13, 2023

Marinol, also known as Dronabinol, is a medication used to treat a variety of conditions, including nausea and vomiting caused by chemotherapy, loss of appetite and weight loss in people with HIV/AIDS, as well as chronic pain. The dosage and treatment duration may vary depending on the patient’s specific condition and medical history.

THC 98

THC Chronic Pain Treatment Conditions 98

The Cannigma

JUNE 4, 2023

The South American country has a rich cultural history of cannabis use, with indigenous communities using it for medicinal, spiritual, and cultural practices for centuries. Patients with qualifying medical conditions can access cannabis-based products with a prescription from authorized healthcare professionals.

Law 52

Law Seed-To-Sale Research and Development Cultivation 52

Veriheal

OCTOBER 13, 2020

Ulcerative Colitis is a condition that causes long-lasting inflammation and ulcers (sores) in the innermost lining of the individual’s large intestine and rectum. Crohn’s Disease is also a condition that causes inflammation, but it affects the lining of the digestive tract, which can then spread deeply into the affected tissues. .

Digestion 123

Digestion Treatment Conditions Research and Development 123

Greencamp

AUGUST 16, 2018

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Modern science hasn’t found a cure for this condition so far, and the most frequent cause of death is respiratory failure due to muscle decay.

Strains 94

Strains Cannabinoids Research and Development Indica 94

United Patients Group

JUNE 26, 2023

They often possess a more profound understanding of healthcare policies, advanced practice procedures, and innovative research methodologies. These comprehensive programs focus on developing skills in patient care, policy interpretation, and research methods. Here, nurses have the potential to bridge the gap.

Research and Development 52

Research and Development Education Patients Policy 52

The Cannigma

AUGUST 5, 2022

But today, thanks to a combination of changing laws and attitudes and a building consensus of scientific research, there’s another, perhaps unexpected option – ketamine. Most existing research does not support the use of THC in combating depression and there is very limited data for other cannabinoids.” ” 8 9.

Treatment 138

Treatment Research and Development Therapy Digestion 138

Cannabis Law Report

JULY 1, 2021

On June 30th, the Petrie-Flom Center announced the launch of a three-year research initiative , the Project on Psychedelics Law and Regulation (POPLAR) , which is supported by a generous grant from the Saisei Foundation. POPLAR will publish original law and policy research. What barriers exist to conducting psychedelics research?

Law 105

Law Research and Development Therapy DEA 105

Cannabis Law Report

JUNE 21, 2021

Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. Most of the data came from five states that list these indications as qualifying conditions for the use of medical cannabis. The Upshot.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

JANUARY 27, 2022

If passed the bill will establish the “Task Force on Psilocybin Equity” that will research problems relating to access and equity in Oregon’s emerging psilocybin program. Green Light Law Group assisted in drafting SB 1580 and is pleased to provide background on the bill’s development and future.

Research and Development 52

Research and Development Policy Access Legislation 52

MMJ Recs

OCTOBER 5, 2023

The state has developed a comprehensive set of laws to regulate the cultivation, distribution, and use of medical marijuana. These laws are designed to protect patients, provide access to treatment, and prevent abuse. Registered MMJ patients may identify an individual (21 years of age or older) to serve as their caregiver.

Dispensary 52

Dispensary Patients Treatment Conditions 52

Veriheal

JUNE 29, 2021

Plant medicines and concoctions made from them have been utilized throughout the history of cultures around the world. In the last 100 years, many of the plant therapies that were embraced in history were outlawed by governments around the world and replaced by lab-made synthetic drugs we label medicine. A Push by Patients.

Therapy 55

Therapy DEA Patients Clinical Trials 55

Cannabis Info

MARCH 2, 2019

It is only in recent human history, that this mighty herb fell victim to human greed and was bound into the chains of prohibition. Epilepsy is a neurological condition, that directly affects the nervous system and causes seizures in individuals who suffer from the condition. WHAT EXACTLY IS EPILEPSY? CONVENTIONAL TREATMENT.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

Cannabis Law Report

NOVEMBER 24, 2021

Published by The Journal of Cannabis Research. Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. The precis is simple. Background.

Research and Development 52

Research and Development Medicine Access Media 52

Puff Puff Post

DECEMBER 12, 2018

VANCOUVER — Doctors with opposing views on whether medical marijuana should be prescribed for various conditions agree on one thing: their profession is ill-prepared to deal with patients asking for a drug that lacks adequate clinical research. “It’s a tough situation. .” And this is dangerous.

Patients 76

Patients Research and Development Conditions Chronic Pain 76

Kind Meds (Cannabis Education Blog)

JUNE 7, 2021

Cannabis has a complicated history in the United States. however, and the evolution of the cannabis industry has an interesting history spanning thousands of years and dozens of countries. however, and the evolution of the cannabis industry has an interesting history spanning thousands of years and dozens of countries.

Oil 71

Oil History Hemp Tincture 71

The Cannigma

SEPTEMBER 12, 2021

THC is the most prevalent, famous and researched cannabinoid by far. This contradiction, combined with a problematic regulatory framework that limits access to THC products in many states, has created a booming market for d-8 and d-10. The first researcher who identified and isolated THC, was the American Roger Adams (Shutterstock).

THC 98

THC Research and Development Cannabinoids CBD 98

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.

Research and Development 117

Research and Development Education Agriculture Patients 117

MMJ Recs

SEPTEMBER 19, 2023

Common Causes of Chronic Pain Chronic pain is a complex and often debilitating condition, and its underlying causes can vary widely. However, several common factors contribute to the development of chronic pain. Autoimmune diseases like fibromyalgia and conditions like migraines are also frequent contributors to chronic pain.

Chronic Pain 52

Chronic Pain Patients Treatment Therapy 52

Cannabis Law Report

SEPTEMBER 14, 2021

citizens particularly Black, Indigenous and Latino/a/x communities, and preventing further harm caused by collateral consequences of criminalization and intentional barriers to access the rapidly developing legalized market. Mayors Across The U.S. Push Biden And Congress To Legalize Marijuana With A Focus On Racial Equity.

Policy 98

Policy Research and Development Access Cannabis 98

SpeedWeed

JULY 19, 2021

RELATED: Clinical Cannabis: How GB Sciences is Redefining the Industry Through Research. She also co-invented a “drug discovery platform” using artificial intelligence (AI) that is programmed to identify novel, plant-based formulations to treat multiple symptoms of conditions. Now we’re a science company that uses cannabis.

Medicine 52

Medicine Research and Development Chronic Pain Programs 52

Cannabis Law Report

SEPTEMBER 20, 2021

Delic expects to open 15 additional clinics across the country over the coming 18 months, further expanding access to millions who can benefit from psychedelic treatment for a variety of mental health conditions. Established history of providing ketamine infusion services: The management team at KWC has been in ?

Treatment 52

Treatment Media Research and Development Patients 52

Cannabis Law Report

JULY 24, 2022

analyse the history and applications of psychedelic substances such as LSD, psilocybin, MDMA and mescaline. According to experts, research with psychedelics (also known as hallucinogens) or related substances will increase worldwide in the coming years. scientific research, (2.) the development of medicinal products or (3.)

Research and Development 52

Research and Development Legalization Treatment Patients 52

Veriheal

NOVEMBER 22, 2021

While this is somewhat surprising considering the lower costs and taxes of medical marijuana , Headset’s September 2021 report on developments in U.S. While regulation leads to safer, more accessible products, cannabis sold in regulated dispensaries is almost always more expensive than cannabis sold on the illegal market.

Recreational 98

Recreational Data Dispensary Cannabis 98